Anda di halaman 1dari 6

Changing Market Dynamics

Some Recent Challenges

Ron Hartmann, Pharm.D.


VP, Pharmacy
MedAssets Supply Chain Systems

1
Topics
• Genentech’s Distribution Plans
• IVIG/Albumin
• Selected “Late-Stage” Branded
Products

2
Changing Market Dynamics – Recent
Challenges
• Genentech
– Announced change in distribution model for Avastin,
Herceptin, and Rituxan on April 3rd
– Selected Specialty Distributors only as of June 15th
– Primary goal was to improve control and security over
the distribution of these products
– Significant push back from customers
– Efforts of HIGPA Rx Group, ASHP, others = effective
– Genentech announced modified plans on June 13th
that allow most Hospitals to continue purchasing
through their Prime Vendor Wholesaler
Changing Market Dynamics – Recent
Challenges
• IVIG/Albumin
– Extremely tight supply situation right now (like you
didn’t already know that!)
– Demand outpacing supplies/production
– Albumin supplies are even tighter than IVIG
– Continue to work closely with your Distributor
– Use appropriate caution with alternative sources
• Check manufacturer’s Authorized Distributors
• May want to request Product Pedigree
Changing Market Dynamics – Recent Challenges
•Ovation Pharmaceuticals; Sigma-Tau, and similar
manufacturers. Serving a need, however……….

%
% incre %
Cost per Cost per incre ase increa
package package ase vs. se vs.
Trade Name Package 8/05 9/05 9/05 Current Cost 9/05 8/05

COSMEGEN 1 x 0.5mg vial $ 11.68 $ 13.43 15.0% $ 475.05 3437% 3967%

DIURIL SODIUM 1 x 500mg vial $ 8.83 $ 12.36 40.0% $ 119.21 864% 1250%

INDOCIN I.V. 3 x 1 mg vials $ 77.77 $ 108.88 40.0% $1,500.00 1278% 1829%

MUSTARGEN 4 x 10mg vials $ 40.44 $ 50.55 25.0% $ 545.28 979% 1248%

MATULANE 50mg caps #100 $ 58.00 $4,640.00 7900%

5
Thank You!

Questions?